See how the #VisiumHD 3’ whole transcriptome assay powers comprehensive spatial characterization of the tumor microenvironment in our #AACR2025 poster. https://bit.ly/46Q9d6w
RareCyte in collaboration with UCSF developed a novel, highly sensitive assay to detect and characterize CTCs in the cerebrospinal fluid of patients with leptomeningeal disease. Shout out to Laura Huppert who gave an excellent presentation on this work at #AACR2025!
aacrjournals.org/cancerres/ar...
#AACR2025 recap:
•CDR404 (MAGE-A4): Strong activity in "cold" tumors, less T-cell exhaustion, early signs of anti-tumor effect in Ph1
•CDR505 (KK-LC-1): 1st TCE for KK-LC-1+ tumors in HLA-A*01:01 pts—potent, precise, promising
Posters: www.cdr-life.com/our-science/...
Our #AACR2025 Poster on Clinical #Plasma #Proteomics Is Now Available for Download!
📥 biognosys.com/resources/co...
Attending ASMS 2025?
Join our Breakfast Seminar to dive deep into our latest plasma proteomics advancements!
🗓️ Reserve your seat today: biognosys.com/conferences/...
Dr. Rakesh Jain of @mghsteelelabs.bsky.social shared insights from his decades-long work on vascular normalization—from concept to clinic. His lecture emphasized strategies to improve tumor vessel function and how these principles are transforming cancer therapy today.
#AACR2025 @harvard.edu
Couldn't attend #AACR2025? Or just didn't get time for the poster hall? We took a hike around the hall and picked out our favourites and compiled them here to get you all caught up! @theaacr.bsky.social www.biotechniques.com/cancer-resea...
A Proffered Abstract at #AACR2025:
New from the Human Tumor Atlas Network: Multi-modal profiling of HR+ metastatic breast cancer reveals tumor-intrinsic and microenvironmental programs driving CDK4/6 inhibitor resistance.
Largest spatially resolved MBC cohort to date
aacrjournals.org/cancerres/ar...
New data from #AACR2025 show a steep decline in breast cancer deaths among females aged 20–49. Luminal A and triple-negative types saw the biggest drop. Disparities remain for Black women.
Read the full @amjreviews.bsky.social article here: www.emjreviews.com/en-us/amj/on...
#AMJOncology
New Drugs on the Horizon from #AACR2025!
12 clinical molecules, 12 fresh stories from the frontlines of drug discovery.
The full article covers the science, mechanism of action, and clinical context behind each of these new drug compounds.
Read more: t.co/h10fFwojvX
🎪 What a week at #AACR2025 in Chicago! 🙌
Big thanks to everyone who stopped by Booth #406 to explore our latest in cancer research 🦀 — from 2D/3D cell culture to #imaging & #microfluidics.
🔬 Here’s a quick look back!
@theaacr.bsky.social
#eventhighlights #canceresearch
Thanks to everyone who joined us at #AACR2025! 🙌 We shared major #AVITI24 updates, including accelerated DISS rollout 🧬 for spatial, single cell insights. Catch our posters and highlights on CRISPR, Trinity™, and more in our wrap-up ⬇️ bit.ly/4jITE4Q
#DrugDiscovery #CancerResearch
Photo of the official AACR 2025 Sign.
And that’s a wrap on #AACR2025! 🎉
It was a real pleasure connecting with both new and familiar faces. Thanks to everyone who stopped by to chat about single-cell research and what we’re building at ARRALYZE. We really enjoyed the conversations and your curiosity 💚
#SingleCell #Biotech
Josef is back from #AACR2025 in Chicago where he presented his poster on "CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency" 📰🔬
Between the numerous sessions, Josef found time to record a short tour of the conference for all those who stayed at home! Link to video: bit.ly/3RL7ozJ 📽️✨
AACR 2025 in Focus: Top Highlights from the Annual Meeting
@theaacr.bsky.social
oncodaily.com/blog/aacr284...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR2025
SCRI expert, Dr. Stephen Strickland presented interim results for SENTI-202 at #AACR2025. This CAR NK cell therapy shows potential in treating relapsed AML, with several patients achieving complete remission. Read more www.usnews.com/news/health-...
#CancerResearch #CAR_NK_Therapy #AML #USNews
We're still buzzing after our Skyline Spatial Reception at #AACR2025
We met with enthusiastic, passionate scientists that came together to deliver key innovations for cancer research. The ACD team were honored to co-host with Leica Biosystems & @indicalabs.bsky.social definitely a night to remember!
#AACR2025, several rows of empty poster boards, some posters were not even attended. Changing interests and themes, crowds mostly focused on DNA repair/cell cycle inhibitors or Degraders. Not so much on CAR-T, Systems biology is lost in translation, not sure where cancer research is headed.
Feeling grateful after an inspiring #AACR2025 in Chicago. High-impact science, great communication, and insightful conversations around AI in cancer research. I closed with my poster—on how we are using AI to predict the oncogenic effect of noncoding mutations.
Trispecific therapy ISB 2001 active in ongoing early #MM trial
#AACR25 #AACR2025
sohoinsider.com/cellular-the...
The extra plushies aren’t going to waste - we’re honing our juggling skills! A little laughter goes a long way, and our team sure knows how to have fun. 😎 We are excited for day 4! Make sure to swing by booth #2758 before the plushies are all gone! 🐝
#AACR #AACR25 #AACR2025 #CancerResearch #Abbexa
Promising data on D3S-001 at AACR25 - Herbert Loong
@herbloongmd.bsky.social @theaacr.bsky.social
oncodaily.com/science/herb...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR25 #AACR2025 #D3S001
#AACR #AACR2025 #oncology #cancerresearch #NGS #scRNAseq #LiveSeq #epigenetics #singlecell #genomics #cellbiology #FluidFM #CellEngineering #GeneEditing #Research #CRISPR #Innovation #Runners4Research
Final day at #AACR2025! Visit Booth 2741 to meet the MIMETAS team and learn how we can support your cancer research. Check out our 4 posters:
🧬 Liver fibrosis & gene delivery
🧠 GBM-vasculature
🧫 HCC microenvironment
🧪 CAR-T co-culture
Download posters: mimetas.com/en/posters/
@theaacr.bsky.social #AACR2025 I was honored to co-chair the “microRNAs and other noncoding RNAs” session at AACR Chicago. Fantastic talks about small molecule inhibitors and novel targets regulating miRNA function/EV transport and lincRNA activity that could lead to novel RNA medicine for cancer.
Don’t miss this poster (section 2 board 9) today by my friend & colleague Janusz Franco-Barraza from #FoxChaseCancer about the #TME of a unique #Hodgkin #Lymphoma case (using multiplex sequential IF)
#AACR25 #AACR2025 @theaacr.bsky.social
eppro02.ativ.me/appinfo.php?...
#AACR25
Image from article in Radiology: Artificial Intelligence
Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network https://doi.org/10.1148/ryai.240229 #AACR25 #AACR2025 #cancer #OncoRad #oncology
Great session on adaptive therapy chaired by @mathonco.bsky.social Sandy Anderson demonstrating the power of applying math modeling to extend the efficacy of standard of care therapies by preventing the emergence of drug resistant clones #aacr2025 @theaacr.bsky.social @moffittnews.bsky.social
Image from article in Radiology: Artificial Intelligence
Large collection of lung cancer screening low-dose CT scans for lung nodule classification with annotations performed semiautomatically https://doi.org/10.1148/ryai.240248 #AACR25 #AACR2025 #cancer #OncoRad #oncology
It was a pleasure meeting other grantees and colleagues from Latin America at #AACR2025